Aurora Rizzo

423 total citations
10 papers, 322 citations indexed

About

Aurora Rizzo is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Aurora Rizzo has authored 10 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Oncology. Recurrent topics in Aurora Rizzo's work include Epigenetics and DNA Methylation (4 papers), Immunotherapy and Immune Responses (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Aurora Rizzo is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Immunotherapy and Immune Responses (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Aurora Rizzo collaborates with scholars based in Italy, Australia and Ukraine. Aurora Rizzo's co-authors include Luca Sigalotti, Francesca Colizzi, Elisabetta Fratta, Michele Maio, Alessia Covre, Giulia Parisi, Hugues J. M. Nicolay, Sandra Coral, Annunziata Gloghini and Antonino Carbone and has published in prestigious journals such as British Journal of Cancer, Frontiers in Immunology and Cell Death and Disease.

In The Last Decade

Aurora Rizzo

10 papers receiving 313 citations

Peers

Aurora Rizzo

MB

ONCOL

IMMUN

PRM

CR

Amar Bhatnagar India

Tina Nuebling Germany

M.A. García‐Marcos Spain

Yoshiaki Kuroda Japan

X. Frank Zhao United States

JR Downing United States

Shiro Takamatsu Japan

Rawan Faramand United States

Maria J H Boumans Netherlands

Jari Karjalainen Finland

Amar Bhatnagar India

Aurora Rizzo

167 ×1.0

MB

88 ×0.6

ONCOL

73 ×1.1

IMMUN

56 ×1.2

PRM

46 ×1.1

CR

Citations per year, relative to Aurora Rizzo Aurora Rizzo (= 1×) peers Amar Bhatnagar

Countries citing papers authored by Aurora Rizzo

Since Specialization

Citations

This map shows the geographic impact of Aurora Rizzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurora Rizzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurora Rizzo more than expected).

Fields of papers citing papers by Aurora Rizzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurora Rizzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurora Rizzo. The network helps show where Aurora Rizzo may publish in the future.

Co-authorship network of co-authors of Aurora Rizzo

This figure shows the co-authorship network connecting the top 25 collaborators of Aurora Rizzo. A scholar is included among the top collaborators of Aurora Rizzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurora Rizzo. Aurora Rizzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Muraro, Elena, Barbara Montico, Benedict Lum, et al.. (2024). Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors. Frontiers in Immunology. 15. 1336566–1336566. 2 indexed citations

2.

Montico, Barbara, Francesca Colizzi, Giorgio Giurato, et al.. (2020). Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy. Cell Death and Disease. 11(5). 392–392. 13 indexed citations

3.

Furlan, Carlo, Jerry Polesel, Luigi Barzan, et al.. (2017). Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma. Clinical Epigenetics. 9(1). 58–58. 31 indexed citations

4.

Muraro, Elena, Carlo Furlan, Michele Avanzo, et al.. (2017). Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer. Frontiers in Immunology. 8. 1476–1476. 50 indexed citations

5.

Fratta, Elisabetta, Barbara Montico, Aurora Rizzo, et al.. (2016). Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies. Oncotarget. 7(35). 57327–57350. 20 indexed citations

6.

Coral, Sandra, Alessia Covre, Hugues J. M. Nicolay, et al.. (2012). Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications. British Journal of Cancer. 107(7). 1116–1124. 18 indexed citations

7.

Sigalotti, Luca, Alessia Covre, Elisabetta Fratta, et al.. (2010). Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies. Journal of Translational Medicine. 8(1). 56–56. 92 indexed citations

8.

Verde, Nicla La, Claudia Bareggi, Marina Chiara Garassino, et al.. (2008). Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution. Supportive Care in Cancer. 16(11). 1311–1315. 28 indexed citations

9.

Gloghini, Annunziata, et al.. (1995). KP1/CD68 Expression in Malignant Neoplasms Including Lymphomas, Sarcomas, and Carcinomas. American Journal of Clinical Pathology. 103(4). 425–431. 52 indexed citations

10.

Carbone, Antonino, et al.. (1993). Co-expression of Epstein-Barr virus latent membrane protein and vimentin in “aggressive” histological subtypes of Hodgkin's disease. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 422(1). 39–45. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact